Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
about
Surgical and molecular pathology of pancreatic neoplasmsPancreatic cancer surgery: past, present, and futureCurrent status and progress of pancreatic cancer in ChinaTime-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic AdenocarcinomaObstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan.Diagnosis and staging of pancreatic ductal adenocarcinoma.Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer.Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas.Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes.Refinement of screening for familial pancreatic cancer.Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy.The clinical benefit of hyperthermia in pancreatic cancer: a systematic review.Unnecessary preoperative biliary drainage: impact on perioperative outcomes of resectable periampullary tumors.S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway.Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis.Contrast-enhanced ultrasound of small focal solid pancreatic lesions: A must!The resectable pancreatic ductal adenocarcinoma: To FNA or not to FNA? A diagnostic dilemma, introduction.Pancreatic cancer screening.Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma.Controversy on the time to progression of pancreatic ductal adenocarcinoma.Circulating Biomarkers to Identify Patients With Resectable Pancreatic Cancer.UEG Week 2015 Poster PresentationsDiagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysisVisualising the dynamics of live pancreatic microtumours self-organised through cell-in-cell invasion
P2860
Q26748615-1D9D5929-F317-44B5-9D6B-F7E2B198D0CEQ26781555-DB48D80D-B6E5-4096-9ADE-8147509E804AQ26799739-F802D136-7686-4089-979F-AE03DC01DBDCQ31110762-425D7D6B-1F7A-420A-BA6C-4405DE8D8159Q33665450-D028373E-44A6-43EA-8109-FC073FA3F3C8Q35964357-7487E217-6961-47F9-AB39-CD80A8E13A60Q36161453-5EAE8D38-700C-4D96-A6A3-8F8BA753B937Q37116727-9FCED523-16D9-437E-BCA9-9CAF01E34CFFQ37680013-4FFF18CB-3A84-4C5F-9835-CAF7A4932654Q39371341-67C61CEB-F107-4D0D-8120-7C24CABA83B4Q40053297-E84F4EC0-914C-4F49-8747-561AA4679562Q40344810-1DB3D352-CF3F-4466-A1B8-8EA26D9FA618Q40377571-35BA7A65-F220-4427-930A-D121183033F9Q40390981-9BBF2C6E-E83A-4CF9-A551-565C06FF5BBBQ40540462-BA1AD3A2-CDA5-4619-BEEF-A6F5F61DA4F6Q40736844-10D43A31-E8C0-461A-A21E-16B85CE4B657Q47174130-933C58D8-0B1B-4043-A408-6AC7DCDAFDD7Q47822083-3C4C0996-6BBF-470E-934A-53E1695E1CDBQ48099296-C248DC1D-5CD4-4744-94BA-93DC8C0DC5CBQ49467767-DBCDDF8A-4C35-4191-82D3-C793C641A10BQ49490571-8C93A080-7B94-4F4F-A5EC-4C9D040E8BC8Q49507724-0D69F6A2-F300-4CDD-A2D0-FA664CB65DDBQ49507843-877447B1-3DB9-4CC8-B4F0-DC2164E6945DQ50495938-13EA49BE-834F-413D-8862-5B7B78590FA5Q50536698-75332ECB-2144-4291-8E6F-11E9D5629B81Q51749938-AB527F77-5B91-40E8-848F-2FA9C4CDCD89Q53591716-FB25D029-B8BC-4898-8E5C-F353E5C703C0Q53739983-CB0A0832-2360-47DA-A08B-E4D6788EC6B4Q56934656-22AED2E1-F875-4D17-9C13-27ABEADD8B46Q57652933-EBEF7B2E-FE81-43A9-BE49-A7178A8B3155Q58719673-38854938-C963-4909-A7F8-B9F2162E60AE
P2860
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@ast
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@en
type
label
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@ast
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@en
prefLabel
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@ast
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@en
P2093
P2860
P1433
P1476
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
@en
P2093
Amanda L Blackford
Christopher L Wolfgang
Marco Dal Molin
P2860
P304
P356
10.1136/GUTJNL-2014-308653
P407
P577
2015-01-30T00:00:00Z